Pre-Conference Workshops
**Subject to Change**
Your workshop registration will include continental breakfast, lunch buffet, and morning and afternoon coffee breaks. Link your social media posts to our conference using #intnsa43.
Time | Wednesday, October 9 | Room/Location | CEs |
8am – 4:30pm | Workshop A: CARN, CARN-AP Review Course **Recommended for those preparing for the CARN or CARN-AP exam.Objectives:
|
International A | 8 |
8:30am – 4:30pm | Workshop B: Buprenorphine Waiver Training for NPs
This is a special eight-hour buprenorphine waiver training course intended for NPs , CNM, CNS, and CRNA’s. The cost to attend is $50. This special rate and workshop is made possible through sponsorship from the Boston Medical Center Grayken Center for Addiction, and via American Academy of Addiction Psychiatry (AAAP) is the DATA 2000 sponsor for this training. Funding for this initiative was made possible (in part) by grant nos. 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA. **See Description and Sponsor information below.** |
International B | CME: 8, see below |
Workshop B Description
This eight-hour course prepares physicians, nurse practitioners and physician assistants to prescribe buprenorphine to treat opioid use disorder. The curriculum includes the science of addiction as a brain disorder, the pharmacology of buprenorphine, and the regulatory requirements around prescribing this medication. Attendees will learn to screen patients for treatment with buprenorphine and to manage the medication along with the patient’s other medical needs in an office setting such as a primary care clinic. The course fulfills 8 hours of the training needed to obtain a waiver to prescribe buprenorphine. The Drug Addiction Treatment Act of 2000 (DATA 2000) requires physicians to complete 8 hours of approved training in order to be eligible for a waiver, and nurse practitioners and physician assistants to complete 24 hours.
Breakfast and lunch will be provided.
This is an in-person training. There will not be an option to attend via webinar. For questions the day of the event, please call Colleen LaBelle at 617-797-6712.
Objectives
- Receive the training required to apply for a waiver to prescribe buprenorphine to their patients with opioid dependence (addiction).
- Identify and assess patients who are appropriate for treatment with buprenorphine.
- Have the specific knowledge concerning the use of buprenorphine to manage opioid dependence in the outpatient setting.
- Discuss the psychiatric and medical co-morbidities associated with opioid addiction.
Intended Audience
Nurse Practitioners, CNS, CNM, and CRNA.
Sponsored By
Boston Medical Center Grayken Center for Addiction. American Academy of Addiction Psychiatry (AAAP) is the DATA 2000 sponsor for this training. Funding for this initiative was made possible (in part) by grant nos. 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Accreditation Information
CME Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AAAP and the Boston Medical Center Grayken Center for Addiction. AAAP is accredited by the ACCME to provide continuing medical education for providers.
Credit Designation: American Academy of Addiction Psychiatry designates this live activity for a maximum of 8 AMA PRA Category 1 Credits™. Providers should claim only the credit commensurate with the extent of their participation in the activity.